GENEVA, Oct. 15 -- AVERNA THERAPEUTICS LTD filed a patent application (IB2026/053461) for “ENGINEERED RETROTRANSPOSABLE ELEMENT PROTEINS FOR GENE INSERTION”. With publication no. WO/2026/215812, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/7088

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....